Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients JOURNAL OF RHEUMATOLOGY Genovese, M. 2015; 42 (10): 1994
View details for PubMedID 26429208